Antimicrobial resistance companies develop diagnostics, therapeutics and technologies to address infections that no longer respond effectively to existing medicines. Their work supports faster pathogen identification, improved treatment decisions and the development of new approaches to infection control.
This category includes companies working on:
Browse 57 UK antimicrobial resistance companies below.
Natural antimicrobial solutions to reduce livestock antibiotic use
Feed, Food & Future is a life sciences company developing and testing natural antibacterial and antiviral ingredients for the animal feed and livestock industries. Operating from…
Specialty pharma delivering niche medicines and novel drug delivery technology
Therakind is a specialty pharmaceutical company focused on developing niche medicines for difficult-to-treat patient populations, including children and the elderly. The company…
Rapid genomic diagnostic device for sepsis and bacterial infections
GenomeKey is a biotechnology company developing an in vitro diagnostic device that uses whole genome sequencing and machine learning to identify bacteria and their antimicrobial…
Anti-virulence drug discovery from natural bioactive compounds
Neem Biotech is a Wales-based drug discovery company developing novel non-traditional antimicrobial treatments derived from naturally inspired compounds. The company specialises…
Rapid point-of-care molecular diagnostics for infectious disease
Llusern Scientific is a diagnostics company developing portable, rapid molecular diagnostic systems for use at the point of care. Using isothermal amplification technology, the…
Contract research for animal health, aquaculture and biopharmaceutical biosafety
Moredun Scientific is a contract research organisation providing efficacy and safety testing services for veterinary and aquaculture products, and biosafety testing of…
Clinical-stage anti-infectives targeting antimicrobial resistance and infectious disease
NovaBiotics is a clinical-stage biotechnology company developing first-in-class anti-infective therapies for difficult-to-treat infectious diseases, with a focus on antimicrobial…
Computational cell models for novel drug target discovery
Oppilotech is a UK biotechnology company that uses systems biology and machine learning to build high-resolution computational models of cells and bacteria. Its proprietary…
Enzyme-free multiplex RNA diagnostics for rapid clinical decisions
Cambridge Nucleomics is a biotechnology company developing a proprietary nanopore-based platform for rapid, high-multiplexed detection of nucleic acid biomarkers. Its enzyme-free…